Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in Pompe disease: a cohort description

INTRODUCTION: Patients with Glycogen Storage Disease type II (GSDII), an inheritable metabolic myopathy also known as Pompe disease, are considered to be at risk for severe COVID-19 due to a reduced respiratory function and a tendency to be overweight. However, so far little is known about the cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismailova, G., Mackenbach, M. J., van den Hout, J. M. P., van der Ploeg, A. T., Brusse, E., Wagenmakers, M. A. E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894826/
https://www.ncbi.nlm.nih.gov/pubmed/35246221
http://dx.doi.org/10.1186/s13023-022-02268-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894826/
https://www.ncbi.nlm.nih.gov/pubmed/35246221
http://dx.doi.org/10.1186/s13023-022-02268-y

Ejemplares similares